Patent application number | Description | Published |
20100098695 | BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION - The invention provides a polypeptide and a specific partial peptide thereof, as well as a polynucleotide and a specific partial nucleotide thereof, that can be used as a biomarker specific for the brain/nerves or specific for nerve differentiation; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for such a biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of such a biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for such a biomarker, and a reagent comprising the same and the like. | 04-22-2010 |
20100100979 | BIOMARKER SPECIFIC FOR CANCER - It is an object of the present invention to provide diagnostic reagents, pharmaceuticals and the like for particular diseases, and providing means that are useful in developing such reagents, pharmaceuticals and the like. The present invention provides a novel polypeptide and a specific partial peptide thereof, as well as a novel polynucleotide and a specific partial nucleotide thereof, that can be used as cancer-specific biomarkers; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for a cancer-specific biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of a cancer-specific biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for a cancer-specific biomarker, and a reagent comprising them and the like. | 04-22-2010 |
20130095107 | BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION - The invention provides a novel polypeptide and a specific partial peptide thereof, as well as a novel polynucleotide and a specific partial nucleotide thereof, that can be used as a biomarker specific for the brain/nerves or specific for nerve differentiation; an expression vector for such a polynucleotide and a specific partial peptide thereof; a transformant incorporating such an expression vector; an antisense molecule, RNAi-inducing nucleic acid (e.g., siRNA), aptamer, or antibody for such a biomarker, and a composition comprising the same; a mammalian cell or non-human mammal wherein the expression or a function of such a biomarker is regulated; a measuring means (e.g., primer set, nucleic acid probe, antibody, aptamer) for such a biomarker, and a reagent comprising the same and the like. | 04-18-2013 |
Patent application number | Description | Published |
20150151637 | CONSUMED POWER AMOUNT ESTIMATION APPARATUS - According to an embodiment, there is provided a consumed power amount estimation apparatus including an estimation unit configured to estimate a power amount necessary for an electric vehicle having a similar power consumption tendency to run, based on a parameter used to compensate for information affecting power consumption by running of the electric vehicle based on consumed power amount information of each of a plurality of electric vehicles having similar power consumption tendencies. | 06-04-2015 |
20150158393 | CHARGING MANAGEMENT SYSTEM - According to one embodiment, there is provided a charging management system. Based on an estimated duration from a time when an electric vehicle having arrived at each of a charging facilities starts charging until the charging is complete, the system determines the charging facility a charging facility utilization of which is to be recommended to be one of the charging facilities related to a path to a destination which has a shortest maximum wait time from a time when a plurality of electric vehicles arrive at the charging facility until the charging is complete, and reports information indicative of the determined charging facility to the electric vehicle not having arrived at the charging facility. | 06-11-2015 |
20150200971 | POLICY MANAGEMENT SYSTEM, ID PROVIDER SYSTEM, AND POLICY EVALUATION DEVICE - According to one embodiment, a policy management system includes a user terminal, an ID provider system which manages an identity of a user, and a service provider system which provides service data. The ID provider system stores a pair of an old policy and a new policy with respect to each service provider ID. The ID provider system stores information with respect to each service provider ID, the difference-adaptive definition information defining a first condition which is referred to when a date of transmission of an access request message is within a transition period from the old policy to new policy, and a second condition which is referred to when the date of transmission of the access request message is out of the transition period. | 07-16-2015 |
20150251553 | CHARGE MANAGEMENT APPARATUS - According to one embodiment, a charge management apparatus includes an input unit, a first estimation unit, a determination unit, a generation unit, and an output unit. The input unit accepts an input of traffic demand data indicative of a number of vehicles. The first estimation unit estimates charge wait times at plural charge stations based on the traffic demand data. The determination unit compares the estimated charge wait times at the respective charge stations, and determines whether a desired condition is satisfied. The generation unit generates charge recommendation information indicative of a charge station according to a determination result. The output unit outputs the charge recommendation information to an external terminal. | 09-10-2015 |